Other News To Note
MAP Pharmaceuticals Inc., of Mountain View, Calif., said it plans to resubmit its new drug application for Levadex (dihydroergotamine) inhalation aerosol for the acute treatment of migraine in adults in the late third quarter/early fourth quarter.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST